Spleen tyrosine kinase has been shown to coordinate detrimental microglial activity in mouse models of tauopathy, brain trauma, stroke, and inflammation (Schweig et al., 2019; Ye et al., 2020; He et al., 2022; Kim et al., 2022). Here, SYK is linked to stroke disorder.